» Articles » PMID: 38618303

Concurrent Challenges in Idiopathic Hypereosinophilic Syndrome Complicating Beta-Thalassemia Major: A Case Report

Overview
Journal Cureus
Date 2024 Apr 15
PMID 38618303
Authors
Affiliations
Soon will be listed here.
Abstract

This case report highlights the uncommon idiopathic hypereosinophilic syndrome (HES) complicating beta-thalassemia major, presenting a diagnostic and management challenge. Beta-thalassemia major, characterized by impaired beta-globin synthesis, necessitates regular blood transfusions and iron chelation therapy. HES, a rare disorder marked by persistent eosinophilia, adds complexity to the clinical course. We present the case of a 27-year-old male with beta-thalassemia major who developed fever, weakness, and weight loss and was subsequently diagnosed with HES. Treatment involved antibiotics, blood transfusions, and corticosteroids, leading to clinical improvement. This case underscores the need to further understand the relationship between thalassemia and eosinophilia and the importance of comprehensive evaluation in patients with overlapping hematological disorders.

References
1.
Kuang F . Approach to Patients with Eosinophilia. Med Clin North Am. 2019; 104(1):1-14. PMC: 7089574. DOI: 10.1016/j.mcna.2019.08.005. View

2.
Shomali W, Gotlib J . World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019; 94(10):1149-1167. DOI: 10.1002/ajh.25617. View

3.
Weatherall D, Clegg J . Thalassemia--a global public health problem. Nat Med. 1996; 2(8):847-9. DOI: 10.1038/nm0896-847. View

4.
Leru P . Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clin Transl Allergy. 2019; 9:36. PMC: 6657042. DOI: 10.1186/s13601-019-0277-4. View

5.
Roufosse F, Goldman M, Cogan E . Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007; 2:37. PMC: 2045078. DOI: 10.1186/1750-1172-2-37. View